Cefamandole Nafate
規格
42540-40-9CAS番号
255-877-4EC番号
sodium (6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateIUPAC名
C19H17N6NaO6S2化学式
512.5 g/mol分子量
cefamandole nafate; 42540-40-9; Cephamandole nafate; Cefamandol nafato; Bergacef; Cedol; Mandol; Mandolsan; Cefam; Cefamandole Nafate sodium; O-Formylcefamandole sodium; Sodium O-formylcefamandole; DTXSID2022751; Lilly 106223; 8HDO7941DO; NSC-299588; CHEBI:3481; DTXCID502751; RefChem:57266; NSC299588; Cemandil Sodium; Kefadol; Mandokef; MFCD00864877; Sodium (6R,7R)-7-(R)-mandelamido-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate formate (ester); Cefamandole formate sodium salt; Cefaseptolo; Lampomandol; Neocefal; Pavecef; Cefamandole nafate [USAN]; Cefamandole (nafate); Sodium (6R,7R)-7-(R)-mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate formate (ester); sodium (6R,7R)-7-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; NCGC00183035-01; Cefamandol nafato [Spanish]; UNII-8HDO7941DO; Kefandol; EINECS 255-877-4; Mandol (TN); NSC 299588; Cefamandole formate sodium;Cephamandole nafate; Cefamandole nafate CRS; Cefamandole nafate [USAN:USP:INN:BAN]; sodium;(6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cefamandole nafate, 97%; Cefamandole nafate (USP); CHEMBL1618; SCHEMBL181311; orb1221300; orb1302386; CEFAMANDOLE NAFATE [MI]; CEFAMANDOLE NAFATE [VANDF]; CEFAMANDOLE NAFATE [MART.]; CEFAMANDOLE NAFATE [USP-RS]; CEFAMANDOLE NAFATE [WHO-DD]; HY-B1166; MSK12031; Tox21_113487; AKOS015895550; AKOS015961133; AC-1642; CCG-269787; CS-4768; EBC-101066; FC19846; GS-3575; CEFAMANDOLE NAFATE [ORANGE BOOK]; CEFAMANDOLE NAFATE [EP MONOGRAPH]; CEFAMANDOLE NAFATE [USP IMPURITY]; AS-12360; CAS-42540-40-9; NS00089630; T4992; C08102; D00909; EN300-25025857; Q27106102; Z3041521791; (6R,7R)-7-[[(2R)-2-(Formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct -2-ene-2-carboxylic acid sodium; 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((FORMYLOXY)PHENYLACETYL)AMINO)-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, MONOSODIUM SALT, (6R-(6.ALPHA.,7.BETA.(R*))); 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(R*)))-; sodium (6R,7R)-7-((R)-2-(formyloxy)-2-phenylacetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Sodium (6R-(6alpha,7beta(R*)))-7-(((formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; sodium 7beta-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylate; SODIUM(6R,7R)-7-(R)-MANDELAMIDO-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLATE FORMATE(ESTER); sodium;(6R7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate別名
Cefamandole Nafateを含む製品
Cefamandole Nafateを販売する企業
(주
(주)에이프로젠바이오로직스Republic of Korea영진
영진약품(주)Republic of KoreaAD
ACS DOBFAR SPAItalyYX
YANTAI XIANHUA TECHNOLOGY GROUP CO.,LTDChinaCU
China Union Chempharma(Suzhou)Co.,LtdChinaGH
Grand Health Industrial Co LtdChinaQP
Qilu PharmaceuticalChinaAC
AFINE CHEMICALS LIMITEDZC
ZHONGNUO CARING PHARMACEUTICAL DEVELOPMENT(SUZHOU)CO.,LTD.China